ACQUIRED RESISTANCE TO PD-(L)1 BLOCKADE IN PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC)

被引：0
|
作者：
Ricciuti, Biagio [1 ]
Lamberti, Giuseppe [1 ]
Alessi, Joao Victor [1 ]
Pecci, Federica [1 ]
Di Federico, Alessandro [1 ]
Wang, Xinan [2 ]
Barrichello, Adriana [1 ]
Vaz, Victor [1 ]
Pangilinan, Andy [1 ]
Haradon, Danielle [1 ]
Elinton, Lee [1 ]
Nishino, Mizuki [3 ]
Rodig, Scott [3 ]
Sholl, Lynette [3 ]
Awad, Mark [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Harvard TH Chan Sch Publ Hlth, Boston, MA USA
[3] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷
关键词：
D O I：
10.1136/jitc-2022-SITC2022.0528
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
528
引用
收藏
页码：A553 / A554
页数：2
相关论文
共 50 条
  • [41] Mitomycin C enhanced the efficacy of PD-L1 blockade in non-small cell lung cancer
    Luo, Min
    Wang, Fang
    Zhang, Hong
    To, Kenneth K. W.
    Wu, Shaocong
    Chen, Zhen
    Liang, Shaobo
    Fu, Liwu
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5 (01)
  • [42] Neoadjuvant PD-(L)1 blockade plus platinum-based chemotherapy for potentially resectable oncogene-positive non-small cell lung cancer
    Zhang, Xuchen
    Zhang, Hefeng
    Hou, Feng
    Fang, Tao
    Zhang, Chuantao
    Wang, Huiyun
    Song, Shanai
    Lan, Hongwei
    Wang, Yongjie
    Hou, Helei
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2024, 22 (01)
  • [43] Combination therapy with PD-1/PD-L1 blockade in non-small cell lung cancer: strategies and mechanisms
    Huang, Mu-Yang
    Jiang, Xiao-Ming
    Wang, Bing-Lin
    Sun, Yang
    Lu, Jin-Jian
    PHARMACOLOGY & THERAPEUTICS, 2021, 219
  • [44] Non-small cell lung cancer (NSCLC) in elderly patients
    Batura-Gabryel, H.
    Brajer, B.
    LUNG CANCER, 2006, 52 : S19 - S19
  • [45] Non-Small Cell Lung Cancer, PD-L1, and the Pathologist
    Kerr, Keith M.
    Nicolson, Marianne C.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2016, 140 (03) : 249 - 254
  • [46] Biomarker evaluation for PD-1 targeted therapies in non-small cell lung cancer (NSCLC) patients
    Kamphorst, Alice O.
    Pillai, Rathi N.
    Yang, Shu
    Akondy, Rama
    Koenig, Lydia
    Yu, Ke
    McCausland, Megan
    Sica, Gabriel
    Khuri, Fadlo R.
    Owonikoko, Taofeek K.
    Ramalingam, Suresh S.
    Ahmed, Rafi
    CANCER RESEARCH, 2015, 75
  • [47] Liquid Biopsy Based Monitoring of PD-L1 Expression in Non-Small Cell Lung Cancer (NSCLC) Patients for Immunotherapy
    Singh, G.
    Leong, M.
    Sylvester, S.
    Lee, Y.
    Johnson, C.
    Wu, A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (06): : 1006 - 1006
  • [48] Characterization of PD-L1 expression in circulating tumor cells (CTCs) of non-small cell lung cancer (NSCLC) patients
    Krupa, R.
    Lu, D.
    Harvey, M.
    Louw, J.
    Jendrisak, A.
    Marrinucci, D.
    Dittamore, R.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 45 - 45
  • [49] Role of EBUS-TBNA in the study of PD-L1 expression in patients with non-small cell lung cancer (NSCLC)
    Puig Sanchez, Francisco Guillermo
    Roman Rodriguez, Lucas
    Barca Hernando, Maria
    Marquez Martin, Eduardo
    Romero Romero, Beatriz
    Martin Juan, Jose
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [50] Association between soluble PD-L1 and prognosis of non-small cell lung cancer (NSCLC) patients treated with immunotherapy
    Dellepiane, C.
    Coco, S.
    Dal Bello, M. G.
    Rossi, G.
    Rijavec, E.
    Biello, F.
    Tagliamento, M.
    Longo, L.
    Mora, M.
    Anselmi, G.
    Alama, A.
    Bennicelli, E.
    Grossi, F.
    Zullo, L.
    Beshiri, K.
    Bottini, A.
    Pronzato, P.
    Genova, C.
    ANNALS OF ONCOLOGY, 2020, 31 : S851 - S851
12345